BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
36.4616629
NSE Symbol
MARKSANS
Divident Yield %
0.27
Market Cap
(Rs In Cr.)
15,090
P/E (TTM)
46.9
EPS (TTM)
7.1
Face Value
(Rs)
1
Date Heading
12-Aug-26 Marksans Pharma consolidated net profit rises 169.50% in the June 2026
12-Aug-26 Marksans Pharma soars as Q1 PAT zooms 174% YoY
31-Jul-26 Marksans Pharma to discuss results
22-Jul-26 Marksans Pharma Ltd Falls 5.24%, BSE Healthcare index Drops 1.34%
21-Jul-26 Marksans Pharma completes acquisition of ABCnow GmbH
08-Jul-26 Marksans Pharma inks deal to acquire ABCnow GmbH
08-Jul-26 Marksans Pharma rises after acquiring 100% stake in ABCnow GmbH
03-Jul-26 Marksans Pharma to conduct AGM
16-Jun-26 Marksans Pharma completes of Netherlands-based QliniQ B.V.
09-Jun-26 Marksans Pharma receives revision in ratings outlook for bank faciliti
01-Jun-26 Marksans Pharma to acquire Netherlands-based QliniQ B.V.
26-May-26 Indices witness profit booking; PSU Bank shares snap 5-day rally
26-May-26 Board of Marksans Pharma recommends final dividend
26-May-26 Marksans Pharma consolidated net profit rises 63.59% in the March 2026
26-May-26 Marksans Pharma soars after Q4 PAT jumps 64% YoY
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)